4.7 Review

Immunoglobulin A and liver diseases

Journal

JOURNAL OF GASTROENTEROLOGY
Volume 53, Issue 6, Pages 691-700

Publisher

SPRINGER JAPAN KK
DOI: 10.1007/s00535-017-1400-8

Keywords

IgA; ALD; NAFLD; NASH; Gut microbiome

Funding

  1. JSPS [17K15953]
  2. NIH [R01 AA020703, U01 AA24726, U01 AA021856]
  3. Biomedical Laboratory Research and Development Service of the VA Office of Research and Development [I01BX002213]
  4. NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA024726, U01AA021856, R01AA020703] Funding Source: NIH RePORTER
  5. Veterans Affairs [I01BX002213] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Immunoglobulin A (IgA) is a major immunoglobulin isotype in the gut and plays a role in maintenance of gut homeostasis. Secretory IgA (SIgA) has multiple functions in the gut, such as to regulate microbiota composition, to protect intestinal epithelium from pathogenic microorganisms, and to help for immune-system development. The liver is the front-line organ that receives gut-derived products through the portal vein, implying that the liver could be severely affected by a disrupted intestinal homeostasis. Indeed, some liver diseases like alcoholic liver disease are associated with an altered composition of gut microbiota and increased blood endotoxin levels. Therefore, deficiency of SIgA function appears as a significant factor for the pathogenesis of liver diseases associated with altered gut microbiome. In this review, we describe SIgA functions on the gut microbiome and discuss the role of IgA for liver diseases, especially alcoholic liver disease and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available